Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/2014 - 12/2014

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS, Health care costs, Health care economics, Health care expenditures, Prevalence

Citation

Authors

Schackman BR, Haas DW, Park SS, Li XC, Freedberg KA

Journal

Pharmacogenomics

Volume

Issue

Pages

2007-18

Publication year

2015

Suggested citation

Schackman BR, Haas DW, Park SS, Li XC, Freedberg KA. Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice. Pharmacogenomics. 2015; 16(18): 2007-18.

DOI

10.2217/pgs.15.142

PMID

26607811

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice

Nav